Cheng Deng Buys 366,000 Shares of ZEPP
ZEPP's CFO, Cheng Deng, increased his holdings with a significant purchase.
Key Points
- Cheng Deng, ZEPP's CFO, purchased 366,000 shares on April 1, 2026.
- ZEPP's shares traded around $4.49 on Monday, reflecting market conditions.
- Institutional investors like FIL LTD and Morgan Stanley also adjusted their positions in ZEPP.
Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
Cheng Deng, the Chief Financial Officer of ZEPP, made a notable purchase of 366,000 shares on April 1, 2026. This insider transaction wasn't part of a pre-planned trading scheme. The shares traded near $4.49 on Monday, showing investor interest in the stock.
Other Institutional Activity in ZEPP
Several institutional investors adjusted their stakes in ZEPP recently. FIL LTD increased its holdings by 91,596 shares, ending with 717,352 shares valued at about $8.57 million, marking a 14.6% increase. Morgan Stanley also boosted its position by 97,397 shares to a total of 707,691 shares, worth approximately $8.46 million, reflecting a 16.0% rise. On the other hand, Point72 Asset Management slightly reduced its stake by 294 shares, holding 577,676 shares valued at $6.90 million, a marginal 0.1% decrease. Millennium Management trimmed its position by 24,322 shares, resulting in 342,504 shares valued at $4.09 million, a 6.6% decrease. Meanwhile, Monolith Management grew its position by 40,182 shares, ending with 173,847 shares worth $2.08 million, a significant 30.1% increase.
Zepp Health Corporation Stock Down 10.9%
Shares of ZEPP traded near $4.49 on Monday. The stock's performance is watched closely by investors, with its market movements reflecting broader market trends and the company's strategic positioning.
$ZEPP stock price
Daily closing prices, year to date. Not investment advice.
Insider Buying and Selling at Zepp Health Corporation
Cheng Deng, ZEPP's CFO, was active in trading the company's stock. On June 26, 2026, Deng sold 9,836 shares at an average price of $4.61. On the same day, he acquired 22,875 shares without a specified price and sold 366,000 shares in another transaction, also without a specified price. These transactions were not part of any pre-planned trading arrangements.
Analysts Set New Price Targets
On August 21, 2023, Citi maintained its buy rating on ZEPP with a price target of $3.10. This reflects analysts' views on the company's future performance and potential market position.
About ZEPP
ZEPP is a company engaged in the technology sector, focusing on providing innovative products and solutions. The company's operations are centered around developing and marketing consumer electronics, with a commitment to enhancing user experiences through cutting-edge technology.
Bottom Line
Cheng Deng's recent purchase of ZEPP shares highlights his confidence in the company's prospects. Institutional investors have also been adjusting their positions, reflecting various strategies and market outlooks. As always, keep in mind that insider transactions are reported after they occur and may not indicate current positions.
Get Zepp Health Corporation alerts
New 13F filings, insider trades, and analyst moves on $ZEPP, sent to your inbox. Free, and you can unsubscribe anytime.
This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.
